English
Home > Products > Azlocillin

China Azlocillin Factory

Sticking for the belief of "Creating items of top of the range and creating buddies with people today from all over the world", we normally put the interest of shoppers in the first place for Azlocillin,CAS NO 37091-66-0,37091-66-0,Azlocillin API, Welcome worldwide prospects to get in touch with us for company and long-term cooperation. We'll be your reliable partner and supplier.
Azlocillin, Taking the core concept of "to be the Responsible". We will redound up on society for high quality solutions and good service. We are going to initiative to participate in international competition to be a first- class manufacturer of this product in the world.

Related Products

Hot Products

  • N,9-Diacetylguanine

    N,9-Diacetylguanine

    Product Name:N,9-Diacetylguanine
    Molecular Formula:C9H9N5O3
    Molecular Weight:235.2
    CAS Registry Number:3056-33-5
  • Arginine Acetylsalicylate

    Arginine Acetylsalicylate

    Product Name:Arginine Acetylsalicylate
    Molecular Formula:C15H22N4O6
    Molecular Weight;354.36
    CAS Registry Number;37466-21-0
  • Acetylcysteine

    Acetylcysteine

    Product Name:Acetylcysteine
    Molecular Formula:C5H9NO3S
    Molecular Weight;163.19
    CAS Registry Number;616-91-1
  • Imidazo[1,2-b]pyridazine

    Imidazo[1,2-b]pyridazine

    Product Name:Imidazo[1,2-b]pyridazine
    Molecular Formula:C6H5N3
    Molecular Weight:119.12
    CAS Registry Number:766-55-2
  • Prednisolone

    Prednisolone

    Product Name:Prednisolone
    Molecular Formula:C21H28O5
    Molecular Weight:360.45
    CAS Registry Number;50-24-8
  • Benzene,1,4-bis(1-methylethyl)-,homopolymer

    Benzene,1,4-bis(1-methylethyl)-,homopolymer

    Product Name:Benzene,1,4-bis(1-methylethyl)-,homopolymer
    Molecular Formula:C12H18
    Molecular Weight:162.28
    CAS Registry Number:25822-43-9
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

Azlocillin advance intermediateAzlocillin APIAzlocillin intermediateAzlocillin sodium

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept